Penelope M. Webb

Active 1993–2025

144
Papers
18,034
Citations
77
h-index
136
i10-index

Citations

Citations per year for Penelope M. Webb1972: 1 citations1976: 1 citations1994: 2 citations1995: 5 citations1996: 6 citations1997: 14 citations1998: 15 citations1999: 19 citations2000: 14 citations2001: 19 citations2002: 18 citations2003: 20 citations2004: 17 citations2005: 27 citations2006: 26 citations2007: 45 citations2008: 57 citations2009: 69 citations2010: 101 citations2011: 90 citations2012: 120 citations2013: 165 citations2014: 160 citations2015: 160 citations2016: 174 citations2017: 173 citations2018: 130 citations2019: 491 citations2020: 592 citations2021: 591 citations2022: 483 citations2023: 339 citations2024: 620 citations2025: 309 citations2026: 8 citations1973–1975: no citations, so these years are not shown1977–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,576 citing papers, 19.9% of this breakdownChina: 789 citing papers, 10% of this breakdownUnited Kingdom: 669 citing papers, 8.5% of this breakdownAustralia: 594 citing papers, 7.5% of this breakdownCanada: 362 citing papers, 4.6% of this breakdownItaly: 338 citing papers, 4.3% of this breakdownGermany: 328 citing papers, 4.1% of this breakdownFrance: 247 citing papers, 3.1% of this breakdownJapan: 200 citing papers, 2.5% of this breakdownSpain: 192 citing papers, 2.4% of this breakdownNetherlands: 189 citing papers, 2.4% of this breakdownSweden: 182 citing papers, 2.3% of this breakdown
0%19.9%Other 28.4%

Fields

  • Medicine71.3%
  • Biochemistry, Genetics and Molecular Biology22.2%
  • Immunology and Microbiology1.7%
  • Environmental Science0.8%
  • Nursing0.5%
  • Psychology0.5%
  • Other3%

Topics

  • Ovarian cancer diagnosis and treatment8.4%
  • Endometrial and Cervical Cancer Treatments4.7%
  • PARP inhibition in cancer therapy3.4%
  • BRCA gene mutations in cancer3.2%
  • Cancer Risks and Factors2.7%
  • Endometriosis Research and Treatment2.5%
  • Other75.1%

Coauthors

All papers

Open in search
  1. Global epidemiology of epithelial ovarian cancer

    Authors: , - Nature Reviews Clinical Oncology 2024 cited by 489

  2. Epidemiology of epithelial ovarian cancer

    Authors: , - Best Practice & Research Clinical Obstetrics & Gynaecology 2016 cited by 1,038

  3. Type I and II Endometrial Cancers: Have They Different Risk Factors?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kirsten B. Moysich, Anthony B. Miller, Marjorie L. McCullough, Rayna K. Matsuno, Anthony M. Magliocco, Galina Lurie, Lingeng Lu, Jolanta Lissowska, Xiaolin Liang, James V. Lacey, Laurence N. Kolonel, Brian E. Henderson, Susan E. Hankinson, Niclas Håkansson, Marc T. Goodman, Mia M. Gaudet, Montserrat García‐Closas, Christine M. Friedenreich, Jo L. Freudenheim, Jennifer A. Doherty, Immaculata De Vivo, Kerry S. Courneya, Linda S. Cook, Chu Chen, James R. Cerhan, Hui Cai, Louise A. Brinton, Leslie Bernstein, Kristin E. Anderson, Hoda Anton‐Culver, Leo J. Schouten, Pamela L. Horn‐Ross - Journal of Clinical Oncology 2013 cited by 833

  4. Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jillian A. Hung, K.R. Harrap, T. Sadkowsky, Nirmala Pandeya, M. Malt, A. Mellon, R. Paul Robertson, T. Vanden Bergh, Milissa U. Jones, P. Mackenzie, J. Maidens, K. Nattress, Yoke-Eng Chiew, Annie Stenlake, Harold C. Sullivan, Brian M. Alexander, P. Ashover, Stephen M. Brown, T. Corrish, L. Green, L. M. Jackman, Kaltin Ferguson, Karla Martin, A. Martyn, B. Ranieri, J. White, V. Jayde, Pam Mamers, Leanne Bowes, Laura Galletta, Daniel A. Giles, Joy Hendley, Thomas Schmidt, H. Shirley, C. Ball, Christian D. Young, S. Viduka, Hang Tran, Sanela Bilic, Lydia Glavinas, Julia Brooks, R. Stuart‐Harris, Fred Kirsten, J Rutovitz, P. Clingan, Akisha Glasgow, Anthony Proietto, Stephen Braye, Geoffrey Otton, Jenny Shannon, Tony Bonaventura, James Stewart, Stephen Begbie, Michael Friedländer, Debra Bell, Sally Baron‐Hay, A. Ferrier, G. Gard, David Nevell, Nick Pavlakis, Susan Valmadre, B. Young, C. Camaris, R. Crouch, L. Edwards, Neville F. Hacker, Donald E. Marsden, G.M. Robertson, Philip Beale, Jane Beith and 83 more - Nature Communications 2018 cited by 292

  5. BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 cited by 1,176

  6. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wendy R. Brewster, Hoda Anton‐Culver, Alexandra Gentry-Maharaj, Susan J. Ramus, A R Anderson, Doerthe Brueggmann, Peter A. Fasching, Simon A. Gayther, David G. Huntsman, Usha Menon, Roberta B. Ness, Malcolm C. Pike, Harvey A. Risch, Anna H. Wu, Andrew Berchuck - The Lancet Oncology 2012 cited by 932

  7. The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality

    Authors: , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2022 cited by 167

  8. Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial

    Authors: , , , , , , , , , , , , , , , - BMJ 2023 cited by 110

  9. Interferon-ε is a tumour suppressor and restricts ovarian cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David D.L. Bowtell, Nicole A. de Weerd, Clare L. Scott, Nollaig M. Bourke, Paul J. Hertzog - Nature 2023 cited by 70

  10. Association Between Breastfeeding and Ovarian Cancer Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kathryn L. Terry - JAMA Oncology 2020 cited by 272

  11. The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial

    Authors: , , , , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2023 cited by 34

  12. Prognostic gene expression signature for high-grade serous ovarian cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sián Fereday, Sue Moore, Jillian A. Hung, K.R. Harrap, T. Sadkowsky, Nirmala Pandeya, M. Malt, Anne Mellon, R. Paul Robertson, T. Vanden Bergh, Marsha Jones, P. Mackenzie, J. Maidens, K. Nattress, Yoke-Eng Chiew, Annie Stenlake, Harold C. Sullivan, B. Alexander, P. Ashover, Scott D. Brown, T. Corrish, L. Green, L. M. Jackman, Kaltin Ferguson, Karla Martin, A. Martyn, B. Ranieri, Jeff White, V. Jayde, Pamela Mamers, Leanne Bowes, Laura Galletta, Daniel A. Giles, Joy Hendley, Kathryn Alsop, Tannin A. Schmidt, H. Shirley, Colleen T. Ball, Christian D. Young, S. Viduka, Hoa Tran, Sanela Bilic, Lydia Glavinas, Julia Brooks, R. Stuart‐Harris, Fred Kirsten, J Rutovitz, P. Clingan, Akisha Glasgow, Anthony Proietto, Stephen Braye, Geoffrey Otton, Jenny Shannon, Tony Bonaventura, Jocelyn M. Stewart, Stephen Begbie, Michael Friedländer, Dany Bell, Sally Baron‐Hay, A. Ferrier, G. Gard, David Nevell, Nick Pavlakis, Susan Valmadre, B. Young, C. Camaris, R. Crouch, L. Edwards, Neville F. Hacker, Donald E. Marsden and 180 more - Annals of Oncology 2020 cited by 173

  13. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ellen L. Goode, Robert A. Vierkant, Melissa C. Larson, Brooke L. Fridley, Claus Høgdall, Joellen M. Schildkraut, Rachel Palmieri Weber, Daniel W. Cramer, Kathryn L. Terry, Elisa V. Bandera, Lisa E. Paddock, Lorna Rodríguez-Rodríguez, Nicolas Wentzensen, Hannah Yang, Louise A. Brinton, Jolanta Lissowska, Estrid Høgdall, Lene Lundvall, Alice S. Whittemore, Valerie McGuire, Weiva Sieh, Joseph H. Rothstein, Rebecca Sutphen, Hoda Anton‐Culver, Argyrios Ziogas, Celeste Leigh Pearce, Anna H. Wu, Penelope M. Webb - British Journal of Cancer 2015 cited by 157

  14. Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Veronica Wendy Setiawan, Rashmi Sinha, Britton Trabert, Penelope M. Webb, Lynne R. Wilkens, Wanghong Xu, Hannah Yang, Wei Zheng, Megan A. Clarke - International Journal of Epidemiology 2023 cited by 47

  15. Estimating the costs of genomic sequencing in cancer control

    Authors: , , , , , , , , , - BMC Health Services Research 2020 cited by 50

  16. Cohort profile: The QSkin Sun and Health Study

    Authors: , , , , , , , , , , - International Journal of Epidemiology 2012 cited by 174

  17. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence

    Authors: , , , , , , , - International Journal of Cancer 2019 cited by 132

  18. Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo‐controlled D‐Health Trial

    Authors: , , , , , , , , , , , , , , , , - Journal of Cachexia Sarcopenia and Muscle 2021 cited by 65

  19. Obesity and the risk of epithelial ovarian cancer: A systematic review and meta-analysis

    Authors: , , , , , - European Journal of Cancer 2007 cited by 366

  20. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

    Authors: , , , , , , , , , _ _, _ _, , , , , , , , , , , , , , , , , , , , Joellen M. Schildkraut, Cathrine Hoyo, Patricia G. Moorman, Rachel Palmieri Weber, Daniel W. Cramer, Allison F. Vitonis, Elisa V. Bandera, Sara H. Olson, Lorna Rodriguez-Rodriguez, Melony King, L A Brinton, Hannah Yang, Montserrat García‐Closas, Jolanta Lissowska, Hoda Anton Culver, Argyrios Ziogas, Simon A. Gayther, Susan J. Ramus, Usha Menon, Aleksandra Gentry‐Maharaj, Penelope M. Webb - Endocrine Related Cancer 2013 cited by 230

  21. Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Penelope M. Webb, Shelley S. Tworoger, Britton Trabert - Journal of Clinical Oncology 2022 cited by 30

  22. How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013

    Authors: , , , , , , , , , - International Journal of Cancer 2017 cited by 395

  23. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case–control study

    Authors: , , , , , - Cancer Causes & Control 2010 cited by 163

  24. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Graham G. Giles, Ellen L. Goode, Maggie Gorman, Christopher A. Haiman, Per Hall, Susan E. Hankinson, Alexander Hein, Peter Hillemanns, Shirley Hodgson, Erling A. Høivik, Elizabeth Holliday, David J. Hunter, Angela Jones, Peter Kraft, Camilla Krakstad, Diether Lambrechts, Loı̈c Le Marchand, Xiaolin Liang, Annika Lindblom, Jolanta Lissowska, Jirong Long, Lingeng Lu, Anthony M. Magliocco, Lynn Martin, Mark McEvoy, Roger L. Milne, Miriam Mints, Rami Nassir, Geoffrey Otton, Claire Palles, Loreall Pooler, Tony Proietto, Timothy R. Rebbeck, Stefan P. Renner, Harvey A. Risch, Matthias Rübner, Ingo B. Runnebaum, Carlotta Sacerdote, Gloria E. Sarto, Fredrick R. Schumacher, Rodney J. Scott, Veronica Wendy Setiawan, Mitul Shah, Xin Sheng, Xiao‐Ou Shu, Melissa C. Southey, Emma Tham, Ian Tomlinson, Jone Trovik, Constance Turman, Jonathan P. Tyrer, David Van Den Berg, Zhaoming Wang, Nicolas Wentzensen, Lucy Xia, Yong‐Bing Xiang, Hannah Yang, Herbert Yu, Wei Zheng, Penelope M. Webb, Deborah J. Thompson, Amanda B. Spurdle, Dylan M. Glubb, Tracy A. O’Mara - International Journal of Cancer 2020 cited by 73